Dr. Steven Daniel Green, MD

Dr. Green practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Green's NPI, 1053792374, was assigned on June 11, 2015. Dr. Green graduated from Indiana University School Of Medicine in 2015. Dr. Green holds New York license 310232.

Dr. Green's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Green's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Green is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Green practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Green's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Green's licenses on file in 2 states: New York and Indiana.

CMS data shows 199 Medicare services from Dr. Green across 4 procedure codes in 2024, for 87 Medicare patients. Medicare paid $15,244 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Dr. Green in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Green's median patient age at 71, with 51% women.

In 2024, Dr. Green wrote 102 Medicare Part D claims for 40 patients. 52% of them were for generic drugs. CMS names the drug for 24 of them, across 1 drug with 11 or more claims each, at $284 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

Dr. Green accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Green as offering telehealth.

Dmand AI links 15 papers to Dr. Green, published from 2015 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Leukemia, Myeloid, Acute, Bridged Bicyclo Compounds, Heterocyclic and Antibodies, Monoclonal. Dr. Green's most frequent co-authors are Pamela Jeannette Sung, MD, PhD, Mark Gregory Faber, DO and Joshua Franklin Zeidner, MD.

CMS Open Payments shows 35 general payments to Dr. Green from 14 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 78% of the total. GlaxoSmithKline, LLC. paid the most, $10,514. It also lists 1 research payment totaling $225 in 2024.

Dr. Green graduated from Indiana University School Of Medicine in 2015.